Works in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, Vol 14, Issue 1

Results: 125
    1

    Erratum.

    Published in:
    2022
    Publication type:
    Correction Notice
    2
    3

    Erratum.

    Published in:
    2022
    Publication type:
    Correction Notice
    4

    Erratum.

    Published in:
    2022
    Publication type:
    Correction Notice
    5
    6
    7
    8

    AD‐associated CSF biomolecular changes are attenuated in KL‐VS heterozygotes.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12383
    By:
    • Driscoll, Ira;
    • Ma, Yue;
    • Lose, Sarah R.;
    • Gallagher, Catherine L.;
    • Johnson, Sterling C.;
    • Asthana, Sanjay;
    • Hermann, Bruce P.;
    • Sager, Mark A.;
    • Blennow, Kaj;
    • Zetterberg, Henrik;
    • Carlsson, Cynthia M.;
    • Engelman, Corinne D.;
    • Dubal, Dena B.;
    • Okonkwo, Ozioma C.
    Publication type:
    Article
    9
    10

    Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimer's disease pathology and neurodegeneration along the Alzheimer's disease continuum.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12381
    By:
    • Moody, Jason F.;
    • Dean, Douglas C.;
    • Kecskemeti, Steve R.;
    • Blennow, Kaj;
    • Zetterberg, Henrik;
    • Kollmorgen, Gwendlyn;
    • Suridjan, Ivonne;
    • Wild, Norbert;
    • Carlsson, Cynthia M.;
    • Johnson, Sterling C.;
    • Alexander, Andrew L.;
    • Bendlin, Barbara B.
    Publication type:
    Article
    11
    12

    Optimizing cCOG, a Web‐based tool, to detect dementia with Lewy Bodies.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12379
    By:
    • van Gils, Aniek M.;
    • van de Beek, Marleen;
    • van Unnik, Annemartijn A. J. M.;
    • Tolonen, Antti;
    • Handgraaf, Dédé;
    • van Leeuwenstijn, Mardou;
    • Lötjönen, Jyrki;
    • van der Flier, Wiesje M.;
    • Lemstra, Afina;
    • Rhodius‐Meester, Hanneke F. M.
    Publication type:
    Article
    13
    14

    Cerebrospinal fluid levels of fatty acid–binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12377
    By:
    • Dhiman, Kunal;
    • Villemagne, Victor L.;
    • Fowler, Christopher;
    • Bourgeat, Pierrick;
    • Li, Qiao‐Xin;
    • Collins, Steven;
    • Rowe, Christopher C.;
    • Masters, Colin L.;
    • Ames, David;
    • Blennow, Kaj;
    • Zetterberg, Henrik;
    • Martins, Ralph N.;
    • Gupta, Veer
    Publication type:
    Article
    15

    Comparing ARIA‐E severity scales and effects of treatment management thresholds.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12376
    By:
    • Klein, Gregory;
    • Scelsi, Marzia A.;
    • Barakos, Jerome;
    • Fiebach, Jochen B.;
    • Bracoud, Luc;
    • Suhy, Joyce;
    • Delmar, Paul;
    • Lyons, Marco;
    • Wojtowicz, Jakub;
    • Bullain, Szofia;
    • Barkhof, Frederik;
    • Purcell, Derk
    Publication type:
    Article
    16

    Plasma p‐tau181/Aβ<sub>1‐42</sub> ratio predicts Aβ‐PET status and correlates with CSF‐p‐tau181/Aβ<sub>1‐42</sub> and future cognitive decline.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12375
    By:
    • Fowler, Christopher J.;
    • Stoops, Erik;
    • Rainey‐Smith, Stephanie R.;
    • Vanmechelen, Eugeen;
    • Vanbrabant, Jeroen;
    • Dewit, Nele;
    • Mauroo, Kimberley;
    • Maruff, Paul;
    • Rowe, Christopher C.;
    • Fripp, Jurgen;
    • Li, Qiao‐Xin;
    • Bourgeat, Pierrick;
    • Collins, Steven J.;
    • Martins, Ralph N.;
    • Masters, Colin L.;
    • Doecke, James D.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Evaluation of dose‐dependent treatment effects after mid‐trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12367
    By:
    • Wang, Guoqiao;
    • Li, Yan;
    • Xiong, Chengjie;
    • McDade, Eric;
    • Clifford, David B.;
    • Mills, Susan L.;
    • Santacruz, Anna M.;
    • Aschenbrenner, Andrew J.;
    • Hassenstab, Jason;
    • Benzinger, Tammie L.S.;
    • Gordon, Brian A.;
    • Fagan, Anne M.;
    • Coalier, Kelley A.;
    • Libre‐Guerra, Jorge J.;
    • McCullough, Austin;
    • Joseph‐Mathurin, Nelly;
    • Chen, Charles D.;
    • Mummery, Catherine;
    • Wendelberger, Barbara A.;
    • Gauthier, Serge
    Publication type:
    Article
    26
    27
    28

    MRI free water as a biomarker for cognitive performance: Validation in the MarkVCID consortium.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12362
    By:
    • Maillard, Pauline;
    • Hillmer, Laura J.;
    • Lu, Hanzhang;
    • Arfanakis, Konstantinos;
    • Gold, Brian T.;
    • Bauer, Christopher E.;
    • Kramer, Joel H.;
    • Staffaroni, Adam M.;
    • Stables, Lara;
    • Wang, Danny J.J.;
    • Seshadri, Sudha;
    • Satizabal, Claudia L.;
    • Beiser, Alexa;
    • Habes, Mohamad;
    • Fornage, Myriam;
    • Mosley, Thomas H.;
    • Rosenberg, Gary A.;
    • Singh, Baljeet;
    • Singh, Herpreet;
    • Schwab, Kristin
    Publication type:
    Article
    29
    30
    31

    Trajectory of clinical symptoms in relation to amyloid chronicity.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12360
    By:
    • Birdsill, Alex C.;
    • Koscik, Rebecca L.;
    • Cody, Karly A.;
    • Jonaitis, Erin M.;
    • Cadman, Robert V.;
    • Erickson, Claire M.;
    • Chin, Nathaniel A.;
    • Przybelski, Robert J.;
    • Carlsson, Cynthia M.;
    • Asthana, Sanjay;
    • Christian, Bradley T.;
    • Eisenmenger, Laura B.;
    • Betthauser, Tobey J.;
    • Johnson, Sterling C.
    Publication type:
    Article
    32
    33
    34
    35
    36

    Combination of gait speed and grip strength to predict cognitive decline and dementia.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12353
    By:
    • Orchard, Suzanne G.;
    • Polekhina, Galina;
    • Ryan, Joanne;
    • Shah, Raj C.;
    • Storey, Elsdon;
    • Chong, Trevor T.‐J.;
    • Lockery, Jessica E.;
    • Ward, Stephanie A.;
    • Wolfe, Rory;
    • Nelson, Mark R.;
    • Reid, Christopher M.;
    • Murray, Anne M.;
    • Espinoza, Sara E.;
    • Newman, Anne B.;
    • McNeil, John J.;
    • Collyer, Taya A.;
    • Callisaya, Michele L.;
    • Woods, Robyn L.
    Publication type:
    Article
    37
    38
    39
    40

    Portuguese version of the CDR plus NACC FTLD: Validation studies.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12355
    By:
    • Lima, Marisa;
    • Tábuas‐Pereira, Miguel;
    • Durães, João;
    • Faustino, Pedro;
    • Simões, Mário R.;
    • Kukull, Walter;
    • Knopman, David S.;
    • Santana, Isabel
    Publication type:
    Article
    41

    Plasma biomarkers predict cognitive trajectories in an ethnoracially and clinically diverse cohort: Mediation with hippocampal volume.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12349
    By:
    • Sapkota, Shraddha;
    • Erickson, Kelsey;
    • Harvey, Danielle;
    • Tomaszewski‐Farias, Sarah E.;
    • Olichney, John M.;
    • Johnson, David K.;
    • Dugger, Brittany N.;
    • Mungas, Dan M.;
    • Fletcher, Evan;
    • Maillard, Pauline;
    • Seshadri, Sudha;
    • Satizabal, Claudia L.;
    • Kautz, Tiffany;
    • Parent, Danielle;
    • Tracy, Russell P.;
    • Maezawa, Izumi;
    • Jin, Lee‐Way;
    • DeCarli, Charles
    Publication type:
    Article
    42

    No difference in retinal fluorescence after oral curcumin intake in amyloid‐proven AD cases compared to controls.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12347
    By:
    • den Haan, Jurre;
    • Hart de Ruyter, Frederique J.;
    • Lochocki, Benjamin;
    • Kroon, Maurice A.G.M.;
    • Kemper, E. Marleen;
    • Teunissen, Charlotte E.;
    • van Berckel, Bart;
    • Scheltens, Philip;
    • Hoozemans, Jeroen J.;
    • de Kreeke, Aleid van;
    • Verbraak, Frank D.;
    • de Boer, Johannes F.;
    • Bouwman, Femke H.
    Publication type:
    Article
    43
    44

    Associations of the Lifestyle for Brain Health index with longitudinal cognition and brain amyloid beta in clinically unimpaired older adults: Findings from the Wisconsin Registry for Alzheimer's Prevention.

    Published in:
    Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12351
    By:
    • Cody, Karly A.;
    • Koscik, Rebecca L.;
    • Erickson, Claire M.;
    • Berman, Sara E.;
    • Jonaitis, Erin M.;
    • Williams, Victoria J.;
    • Mueller, Kimberly D.;
    • Christian, Bradley T.;
    • Chin, Nathanial A.;
    • Clark, Lindsay R.;
    • Betthauser, Tobey J.;
    • Johnson, Sterling C.
    Publication type:
    Article
    45
    46

    Erratum.

    Published in:
    2022
    Publication type:
    Correction Notice
    47
    48
    49
    50